Lataa...
Successful Desensitization of a Patient with Rituximab Hypersensitivity
Rituximab is a monoclonal antibody which targets CD20 in B cells that is used for the treatment of CD20 positive oncologic and hematologic malignancies. Rituximab causes hypersensitivity reactions during infusions. The delay of treatment or loss of a highly efficient drug can be prevented by rapid d...
Tallennettuna:
| Julkaisussa: | Case Reports Immunol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hindawi Publishing Corporation
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4320878/ https://ncbi.nlm.nih.gov/pubmed/25685566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/524507 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|